ID ADAS_HUMAN Reviewed; 658 AA. AC O00116; A5D8U9; Q2TU35; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1997, sequence version 1. DT 25-JAN-2012, entry version 104. DE RecName: Full=Alkyldihydroxyacetonephosphate synthase, peroxisomal; DE Short=Alkyl-DHAP synthase; DE EC=2.5.1.26; DE AltName: Full=Aging-associated gene 5 protein; DE AltName: Full=Alkylglycerone-phosphate synthase; DE Flags: Precursor; GN Name=AGPS; ORFNames=AAG5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Liver; RX MEDLINE=97330864; PubMed=9187299; DOI=10.1016/S0005-2760(97)00014-3; RA de Vet E.C.J.M., van den Broek B.T.E., van den Bosch H.; RT "Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase RT cDNA reveals the presence of a peroxisomal targeting signal 2."; RL Biochim. Biophys. Acta 1346:25-29(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kim J.W.; RT "Identification of a human aging-associated gene."; RL Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Tongue; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102; LYS-169 AND LYS-347, RP AND MASS SPECTROMETRY. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., RA Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., RA Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [7] RP VARIANT RCDP3 HIS-419. RX MEDLINE=98221159; PubMed=9553082; DOI=10.1074/jbc.273.17.10296; RA de Vet E.C.J.M., Ijlst L., Oostheim W., Wanders R.J.A., RA van den Bosch H.; RT "Alkyl-dihydroxyacetonephosphate synthase. Fate in peroxisome RT biogenesis disorders and identification of the point mutation RT underlying a single enzyme deficiency."; RL J. Biol. Chem. 273:10296-10301(1998). RN [8] RP VARIANTS RCDP3 ILE-309 AND PRO-469. RX PubMed=11152660; DOI=10.1093/hmg/10.2.127; RA Thai T.P., Rodemer C., Jauch A., Hunziker A., Moser A., Gorgas K., RA Just W.W.; RT "Impaired membrane traffic in defective ether lipid biosynthesis."; RL Hum. Mol. Genet. 10:127-136(2001). RN [9] RP VARIANTS RCDP3 GLN-182; LYS-471 AND MET-568, AND CHARACTERIZATION OF RP VARIANTS RCDP3 GLN-182; LYS-471 AND MET-568. RX PubMed=21990100; DOI=10.1002/humu.21623; RA Itzkovitz B., Jiralerspong S., Nimmo G., Loscalzo M., Horovitz D.D., RA Snowden A., Moser A., Steinberg S., Braverman N.; RT "Functional characterization of novel mutations in GNPAT and AGPS, RT causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3."; RL Hum. Mutat. 0:0-0(2011). CC -!- CATALYTIC ACTIVITY: 1-acyl-glycerone 3-phosphate + a long-chain CC alcohol = an alkyl-glycerone 3-phosphate + a long-chain acid CC anion. CC -!- COFACTOR: FAD. CC -!- PATHWAY: Glycerolipid metabolism; ether lipid biosynthesis. CC -!- SUBUNIT: May be part of an heterotrimeric complex composed of DAP- CC AT, ADAP-S and a modified form of DAP-AT. CC -!- SUBCELLULAR LOCATION: Peroxisome membrane. Note=Localized to the CC inner aspect of the peroxisomal membrane. CC -!- DISEASE: Defects in AGPS are the cause of rhizomelic CC chondrodysplasia punctata type 3 (RCDP3) [MIM:600121]. RCDP3 is CC characterized by rhizomelic shortening of femur and humerus, CC vertebral disorders, cataract, cutaneous lesions and severe mental CC retardation. CC -!- SIMILARITY: Belongs to the FAD-binding oxidoreductase/transferase CC type 4 family. CC -!- SIMILARITY: Contains 1 FAD-binding PCMH-type domain. CC -!- WEB RESOURCE: Name=GeneReviews; CC URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/AGPS"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; Y09443; CAA70591.1; -; mRNA. DR EMBL; AY544121; AAT11152.1; -; mRNA. DR EMBL; AK314259; BAG36924.1; -; mRNA. DR EMBL; BC141820; AAI41821.1; -; mRNA. DR IPI; IPI00010349; -. DR RefSeq; NP_003650.1; NM_003659.3. DR UniGene; Hs.516543; -. DR ProteinModelPortal; O00116; -. DR SMR; O00116; 82-657. DR IntAct; O00116; 3. DR STRING; O00116; -. DR PhosphoSite; O00116; -. DR PeptideAtlas; O00116; -. DR PRIDE; O00116; -. DR Ensembl; ENST00000264167; ENSP00000264167; ENSG00000018510. DR GeneID; 8540; -. DR KEGG; hsa:8540; -. DR UCSC; uc002ull.2; human. DR CTD; 8540; -. DR GeneCards; GC02P178221; -. DR H-InvDB; HIX0029990; -. DR HGNC; HGNC:327; AGPS. DR HPA; HPA030209; -. DR HPA; HPA030210; -. DR HPA; HPA030211; -. DR MIM; 600121; phenotype. DR MIM; 603051; gene. DR neXtProt; NX_O00116; -. DR Orphanet; 177; Chondrodysplasia punctata, rhizomelic type. DR PharmGKB; PA24624; -. DR eggNOG; prNOG05503; -. DR HOGENOM; HBG383004; -. DR HOVERGEN; HBG004179; -. DR InParanoid; O00116; -. DR OMA; YNDSKFF; -. DR OrthoDB; EOG44XJGD; -. DR PhylomeDB; O00116; -. DR Reactome; REACT_22258; Metabolism of lipids and lipoproteins. DR NextBio; 31988; -. DR ArrayExpress; O00116; -. DR Bgee; O00116; -. DR CleanEx; HS_AGPS; -. DR Genevestigator; O00116; -. DR GermOnline; ENSG00000018510; Homo sapiens. DR GO; GO:0005730; C:nucleolus; IDA:HPA. DR GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome. DR GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell. DR GO; GO:0008609; F:alkylglycerone-phosphate synthase activity; IDA:MGI. DR GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro. DR GO; GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro. DR GO; GO:0008611; P:ether lipid biosynthetic process; TAS:Reactome. DR InterPro; IPR016166; FAD-bd_2. DR InterPro; IPR016167; FAD-bd_2_sub1. DR InterPro; IPR016164; FAD-linked_Oxase-like_C. DR InterPro; IPR016168; FAD-linked_Oxase_FAD-bd_sub2. DR InterPro; IPR004113; FAD-linked_oxidase_C. DR InterPro; IPR006094; Oxid_FAD_bind_N. DR InterPro; IPR016171; Vanillyl_alc_oxidase_C-sub2. DR Gene3D; G3DSA:3.30.43.10; FAD-binding_2_sub1; 1. DR Gene3D; G3DSA:3.30.465.20; FAD-linked_oxidase_FAD-bd_sub2; 1. DR Gene3D; G3DSA:1.10.45.10; Vanillyl_alc_oxidase_C-sub2; 1. DR KO; K00803; -. DR Pfam; PF02913; FAD-oxidase_C; 1. DR Pfam; PF01565; FAD_binding_4; 1. DR SUPFAM; SSF55103; FAD-binding_2; 1. DR SUPFAM; SSF56176; FAD-binding_2; 1. DR PROSITE; PS51387; FAD_PCMH; 1. PE 1: Evidence at protein level; KW Acetylation; Cataract; Complete proteome; Disease mutation; Dwarfism; KW FAD; Flavoprotein; Lipid synthesis; Membrane; Peroxisome; KW Phosphoprotein; Reference proteome; KW Rhizomelic chondrodysplasia punctata; Transferase; Transit peptide. FT TRANSIT 1 58 Peroxisome (By similarity). FT CHAIN 59 658 Alkyldihydroxyacetonephosphate synthase, FT peroxisomal. FT /FTId=PRO_0000020431. FT DOMAIN 202 384 FAD-binding PCMH-type. FT COMPBIAS 2 8 Poly-Ala. FT ACT_SITE 578 578 By similarity. FT MOD_RES 65 65 Phosphoserine (By similarity). FT MOD_RES 102 102 N6-acetyllysine. FT MOD_RES 169 169 N6-acetyllysine. FT MOD_RES 347 347 N6-acetyllysine. FT VARIANT 182 182 R -> Q (in RCDP3; severely reduced FT protein levels). FT /FTId=VAR_066929. FT VARIANT 309 309 T -> I (in RCDP3). FT /FTId=VAR_025895. FT VARIANT 419 419 R -> H (in RCDP3). FT /FTId=VAR_005002. FT VARIANT 469 469 L -> P (in RCDP3). FT /FTId=VAR_025896. FT VARIANT 471 471 E -> K (in RCDP3; severely reduced FT protein levels). FT /FTId=VAR_066930. FT VARIANT 568 568 T -> M (in RCDP3; does not affect protein FT levels). FT /FTId=VAR_066931. SQ SEQUENCE 658 AA; 72912 MW; 0E97AE86B513DF32 CRC64; MAEAAAAAGG TGLGAGASYG SAADRDRDPD PDRAGRRLRV LSGHLLGRPR EALSTNECKA RRAASAATAA PTATPAAQES GTIPKKRQEV MKWNGWGYND SKFIFNKKGQ IELTGKRYPL SGMGLPTFKE WIQNTLGVNV EHKTTSKASL NPSDTPPSVV NEDFLHDLKE TNISYSQEAD DRVFRAHGHC LHEIFLLREG MFERIPDIVL WPTCHDDVVK IVNLACKYNL CIIPIGGGTS VSYGLMCPAD ETRTIISLDT SQMNRILWVD ENNLTAHVEA GITGQELERQ LKESGYCTGH EPDSLEFSTV GGWVSTRASG MKKNIYGNIE DLVVHIKMVT PRGIIEKSCQ GPRMSTGPDI HHFIMGSEGT LGVITEATIK IRPVPEYQKY GSVAFPNFEQ GVACLREIAK QRCAPASIRL MDNKQFQFGH ALKPQVSSIF TSFLDGLKKF YITKFKGFDP NQLSVATLLF EGDREKVLQH EKQVYDIAAK FGGLAAGEDN GQRGYLLTYV IAYIRDLALE YYVLGESFET SAPWDRVVDL CRNVKERITR ECKEKGVQFA PFSTCRVTQT YDAGACIYFY FAFNYRGISD PLTVFEQTEA AAREEILANG GSLSHHHGVG KLRKQWLKES ISDVGFGMLK SVKEYVDPNN IFGNRNLL //